ArticleJournal of clinical medicine2026
Artificial Intelligence as a Safeguard for Clinical Scientific Integrity: A Human-AI Hybrid Model for Medical Peer Review.
Article in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Peer review is the cornerstone of scholarly publishing and, in medicine, the ultimate guarantor of the reliability of clinical evidence that informs guidelines, therapeutic strategies, and patient care. However, the current peer review system is increasingly strained by bias, abuse, and reviewer overload. Favoritism toward prominent authors, editorial "nepotism," coercive citation practices, superficial evaluations, and even documented cases of idea theft from confidential manuscripts undermine the trustworthiness of the scientific literature upon which clinical decisions depend. In this paper, we argue that artificial intelligence (AI) and large language models (LLMs) offer a transformative opportunity to strengthen the integrity and efficiency of medical peer review. AI-driven tools can perform rapid consistency checks, detect statistical errors or plagiarism, and enforce compliance with ethical and methodological standards across thousands of manuscripts. Early implementations of AI-guided review platforms, plagiarism detectors, and citation-anomaly algorithms demonstrate that machine assistance can make reviews more thorough, objective, and reproducible. At the same time, we acknowledge the limitations of AI, including hallucinations, a lack of human judgment, and risks to confidentiality if misused. To address these concerns, we propose a hybrid model in which AI handles routine screening and technical tasks under strict safeguards, while human experts retain final responsibility for scientific evaluation. This human-AI partnership may represent an essential step toward improving the quality, fairness, and reliability of the clinical evidence base.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.